‘Sec. 1. 24-A MRSA §2159-C, sub-§4 is enacted to read:
4. Use of information obtained through direct-to-consumer genetic testing. In connection with the issuance, withholding, extension or renewal of an insurance policy for life, credit life, disability, long-term care, accidental injury, specified disease, hospital indemnity or credit accident insurance or an annuity, an insurer may not request, require, purchase or use information obtained from an entity providing direct-to-consumer genetic testing without the informed written consent of the individual who has been tested.’